Related Experiment Video
Updated: Aug 24, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
The 2001 serological survey in the Czech Republic--invasive meningococcal disease
1National Reference Laboratory for Meningococcal Infections, National Institute of Public Health, Prague, Czech Republic. pavla.krizova@szu.cz
Abstract:
In 2001, 730 sera from the population of 14 areas of the Czech Republic aged between 1 and 64 years were tested by a microplate assay for the presence of bactericidal antibodies against N. meningitidis A:4,21:P1. 10, N. meningitidis B:2a:P1.2,P1.5 and N. meningitidis C:2a:P1.2,P1.5. The Czech population showed high immunity against N. meningitidis A:4,21:P1.10, but low immunity against N. meningitidis B:2a:P1.2,P1.5 and N. meningitidis C:2a:P1.2,P1.5. The current epidemiological situation requires neither vaccination against meningococcus A nor inclusion of conjugated vaccine against meningococcus C into routine vaccination. Nevertheless, the invasive meningococcal disease surveillance programme needs to be continued since enabling rapid detection of possible changes in the epidemiological situation and subsequent vaccination intervention, if epidemiologically indicated. Conjugated vaccine against meningococcus C should replace polysaccharide vaccine A+C in all indications currently relevant in the Czech Republic.
Insights
The Czech population has high immunity to meningococcus A but low immunity to meningococcus B and C. Continued surveillance is recommended, with meningococcus C conjugate vaccine replacing older A+C vaccines.
Area of Science:
- Immunology
- Epidemiology
- Microbiology
Background:
- Neisseria meningitidis (meningococcus) is a leading cause of bacterial meningitis.
- Meningococcal disease outbreaks necessitate understanding population immunity.
Purpose of the Study:
- To assess the immunity of the Czech population against specific serogroups of Neisseria meningitidis.
- To inform vaccination strategies based on current epidemiological data.
Main Methods:
- A microplate assay was used to test 730 serum samples from diverse age groups in the Czech Republic.
- Antibody presence against N. meningitidis serogroups A, B, and C was quantified.
Main Results:
- High levels of bactericidal antibodies against N. meningitidis serogroup A were observed.
- Low immunity was detected against N. meningitidis serogroups B and C.
Conclusions:
- Current vaccination recommendations do not necessitate routine meningococcus A vaccination.
- Invasive meningococcal disease surveillance should continue for early detection of changes.
- Meningococcus C conjugate vaccine is recommended to replace the polysaccharide A+C vaccine in the Czech Republic.
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis II: Pathophysiology

